Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Lists LCs, Mass Specs as Class I Devices with FDA

NEW YORK (GenomeWeb News) – Agilent Technologies today said that it has listed certain of its liquid chromatography and mass spectrometers as Class I medical devices with the US Food and Drug Administration.

The instruments that were listed are the company's Infinity Series 1200 LC platforms and 6000 Series mass specs. Class I classification is for devices that pose the least risk to patients and Class I devices are the least regulated under FDA's three classifications.

"The latest generation of liquid chromatography and mass spec systems that Agilent has registered holds tremendous value for the medical community, "Gustavo Salem, vice president and general manager of Agilent's Biological Systems Division, said in a statement. "We're being very methodical in bringing this technology to the clinic, while ensuring that the equipment meets the laboratories' needs."

The two systems are manufactured in facilities that are registered with FDA as medical device establishments, a requirement for manufacturing medical devices, Agilent said, adding that in September the facilities were ISO 13485 certified.

In June, Agilent registered its reagent manufacturing facility in Cedar Creek, Texas with FDA as a medical device establishment. At the time the company said it intended to manufacture diagnostic products.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.